Jackson Square Partners LLC Sells 965,268 Shares of Stevanato Group S.p.A. $STVN

Jackson Square Partners LLC lowered its position in shares of Stevanato Group S.p.A. (NYSE:STVNFree Report) by 83.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 192,669 shares of the company’s stock after selling 965,268 shares during the quarter. Stevanato Group accounts for about 1.7% of Jackson Square Partners LLC’s investment portfolio, making the stock its 16th biggest holding. Jackson Square Partners LLC owned about 0.06% of Stevanato Group worth $4,707,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its position in shares of Stevanato Group by 16.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company’s stock valued at $3,324,000 after purchasing an additional 23,545 shares during the period. Raymond James Financial Inc. increased its position in shares of Stevanato Group by 77.4% during the first quarter. Raymond James Financial Inc. now owns 468,475 shares of the company’s stock worth $9,566,000 after acquiring an additional 204,391 shares in the last quarter. LPL Financial LLC raised its stake in shares of Stevanato Group by 35.4% in the 1st quarter. LPL Financial LLC now owns 116,060 shares of the company’s stock valued at $2,250,000 after purchasing an additional 30,339 shares during the period. Bar Harbor Wealth Management bought a new position in shares of Stevanato Group during the 2nd quarter worth approximately $9,081,000. Finally, Mutual of America Capital Management LLC raised its holdings in shares of Stevanato Group by 6.5% in the second quarter. Mutual of America Capital Management LLC now owns 707,123 shares of the company’s stock valued at $17,275,000 after purchasing an additional 43,389 shares during the last quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy”.

View Our Latest Stock Analysis on Stevanato Group

Stevanato Group Trading Down 1.5%

Shares of NYSE:STVN opened at €24.05 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79. Stevanato Group S.p.A. has a 52-week low of €17.49 and a 52-week high of €28.00. The company has a 50-day simple moving average of €25.38 and a 200 day simple moving average of €24.21. The company has a market capitalization of $7.28 billion, a P/E ratio of 42.20, a price-to-earnings-growth ratio of 2.41 and a beta of 0.56.

Stevanato Group Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.